Literature DB >> 7096921

Elevated serum thyroxine concentration in patients receiving "replacement" doses of levothyroxine.

J C Ingbar, M Borges, S Iflah, R E Kleinmann, L E Braverman, S H Ingbar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096921     DOI: 10.1007/BF03350495

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  26 in total

Review 1.  Thyroid hormone therapy.

Authors:  S Refetoff
Journal:  Med Clin North Am       Date:  1975-09       Impact factor: 5.456

2.  Serum thyroid hormone levels in patients on thyroxine replacement therapy.

Authors:  L E Murchison; M I Chesters; P D Bewsher
Journal:  Horm Metab Res       Date:  1976-07       Impact factor: 2.936

3.  Evaluation of a simplified technique for the specific measurement of serum thyroxine concentration.

Authors:  L E Braverman; A G Vagenakis; A E Foster; S H Ingbar
Journal:  J Clin Endocrinol Metab       Date:  1971-04       Impact factor: 5.958

4.  Replacement dosage of L-thyroxine in hypothyroidism. A re-evaluation.

Authors:  J M Stock; M I Surks; J H Oppenheimer
Journal:  N Engl J Med       Date:  1974-03-07       Impact factor: 91.245

Review 5.  Series on pharmacology in practice. 5. Thyroid hormones.

Authors:  M D Brennan
Journal:  Mayo Clin Proc       Date:  1980-01       Impact factor: 7.616

6.  Nonequality of brand name thyroxine preparations.

Authors:  J M Jacobson; A Ramos-Gabatin; R L Young; S C Watkins; M L Brown
Journal:  JAMA       Date:  1980 Feb 22-29       Impact factor: 56.272

7.  Equivalence of thyroid preparations.

Authors: 
Journal:  JAMA       Date:  1980-09-05       Impact factor: 56.272

Review 8.  Drug therapy reviews: management of hypothyroidism.

Authors:  W E Cobb; I M Jackson
Journal:  Am J Hosp Pharm       Date:  1978-01

9.  Serum thyroxine levels in patients receiving L-thyroxine suppression or replacement therapy.

Authors:  A Kahn
Journal:  Can Med Assoc J       Date:  1973-08-18       Impact factor: 8.262

10.  Evidence that triiodothyronine and reverse triiodothyronine are sequentially deiodinated in man.

Authors:  T Sakurada; M Rudolph; S L Fang; A G Vagenakis; L E Braverman; S H Ingbar
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

View more
  9 in total

Review 1.  Resistance to thyroid hormone.

Authors:  R E Weiss; S Refetoff
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Euthyroid hyperthyroxinaemia.

Authors:  V Rippere
Journal:  J R Soc Med       Date:  1988-06       Impact factor: 5.344

3.  'Tissue thyrotoxicosis'.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02

Review 4.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

Review 5.  Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?

Authors:  Matthew D Ettleson; Antonio C Bianco
Journal:  J Clin Endocrinol Metab       Date:  2020-09-01       Impact factor: 5.958

6.  Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for "tissue thyrotoxicosis".

Authors:  P E Jennings; B P O'Malley; K E Griffin; B Northover; F D Rosenthal
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

7.  Evaluation of L-thyroxine replacement therapy in children with congenital hypothyroidism.

Authors:  L Chiovato; L Giusti; M Tonacchera; M Ciampi; C Mammoli; F Lippi; P Lapi; S Bargagna; P Dini; G Ferretti
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

8.  Suppression of peripheral blood natural killer cell activity by excess thyroid hormone.

Authors:  M Papic; J Stein-Streilein; M Zakarija; J M McKenzie; J Guffee; M A Fletcher
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

9.  Thyroxine uptake by human hepatoma cells from serum of patients submitted to long-term thyroxine suppressive therapy.

Authors:  L Bartalena; E Martino; M Falcone; A Pacchiarotti; A Pinchera
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.